Organigram (OGI) Competitors C$2.07 +0.04 (+1.97%) (As of 11/20/2024 ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades OGI vs. CMED, WEED, EMC, ICC, LEAF, MGW, BE, BLO, SL, and MJNShould you be buying Organigram stock or one of its competitors? The main competitors of Organigram include CanniMed Therapeutics (CMED), Canopy Growth (WEED), Emblem (EMC), ICC Labs (ICC), Leaf Mobile (LEAF), Maple Leaf Green World (MGW), Beleave (BE), Cannabix Technologies (BLO), Supreme Cannabis Company Inc, (SL), and Cronos Group (MJN). These companies are all part of the "cannabis" industry. Organigram vs. CanniMed Therapeutics Canopy Growth Emblem ICC Labs Leaf Mobile Maple Leaf Green World Beleave Cannabix Technologies Supreme Cannabis Company Inc, Cronos Group Organigram (TSE:OGI) and CanniMed Therapeutics (TSE:CMED) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, media sentiment, institutional ownership, analyst recommendations, community ranking, dividends and risk. Which has better valuation & earnings, OGI or CMED? CanniMed Therapeutics has lower revenue, but higher earnings than Organigram. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOrganigramC$149.21M1.51-C$229.48M-C$2.51-0.82CanniMed TherapeuticsN/AN/AN/AN/AN/A Do analysts prefer OGI or CMED? Organigram currently has a consensus price target of C$3.98, suggesting a potential upside of 92.03%. Given Organigram's stronger consensus rating and higher probable upside, analysts clearly believe Organigram is more favorable than CanniMed Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Organigram 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75CanniMed Therapeutics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Does the MarketBeat Community prefer OGI or CMED? CanniMed Therapeutics received 109 more outperform votes than Organigram when rated by MarketBeat users. Likewise, 75.85% of users gave CanniMed Therapeutics an outperform vote while only 44.86% of users gave Organigram an outperform vote. CompanyUnderperformOutperformOrganigramOutperform Votes4844.86% Underperform Votes5955.14% CanniMed TherapeuticsOutperform Votes15775.85% Underperform Votes5024.15% Is OGI or CMED more profitable? CanniMed Therapeutics has a net margin of 0.00% compared to Organigram's net margin of -153.80%. CanniMed Therapeutics' return on equity of 0.00% beat Organigram's return on equity.Company Net Margins Return on Equity Return on Assets Organigram-153.80% -54.53% -5.56% CanniMed Therapeutics N/A N/A N/A Do insiders and institutionals have more ownership in OGI or CMED? 8.4% of Organigram shares are owned by institutional investors. 31.3% of Organigram shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term. Does the media prefer OGI or CMED? In the previous week, Organigram's average media sentiment score of 0.46 beat CanniMed Therapeutics' score of 0.00 indicating that Organigram is being referred to more favorably in the media. Company Overall Sentiment Organigram Neutral CanniMed Therapeutics Neutral SummaryOrganigram beats CanniMed Therapeutics on 7 of the 12 factors compared between the two stocks. Ad WealthPressThis Bull Market Indicator called NVDA at $116Every now and again we find an investment idea so incredible we can’t help but share. And today is one of those rare days… Except, today we won't be giving you insight on any one particular stock… But rather, insight on a revolutionary new stock picking indicator… In fact, within the last year, this indicator has become famous for a multitude of reasons… But one of the biggest was because of the buy signal it issued on October 18th, 2022. In fact, on that very day, it said to buy NVDA at $116.37… Anyone who did would be sitting on a tremendously large return today… But even if you missed the original buy signal from October, this incredible indicator issued 11 other buy signals while Nvidia made its epic run…All you have to do is follow this link here Get Organigram News Delivered to You Automatically Sign up to receive the latest news and ratings for OGI and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OGI vs. The Competition Export to ExcelMetricOrganigramDrug Manufacturers IndustryMedical SectorTSE ExchangeMarket CapC$224.74MC$1.17BC$5.05BC$6.25BDividend YieldN/A3.13%4.97%5.27%P/E Ratio-0.82110.0297.3426.84Price / Sales1.512,171.601,218.421,531.29Price / Cash3.8510.4333.5183.81Price / Book0.733.135.803.15Net Income-C$229.48MC$159.31MC$119.07MC$299.38M7 Day Performance-1.43%-1.08%-1.83%0.76%1 Month Performance-15.16%-3.82%-3.64%12.82%1 Year Performance23.21%87.63%31.62%44.03% Organigram Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OGIOrganigram2.9963 of 5 starsC$2.07+2.0%C$3.98+92.0%+16.3%C$224.74MC$149.21M-0.82987CMEDCanniMed TherapeuticsN/AN/AN/AN/AC$668.44MN/A0.00147,000WEEDCanopy Growth1.3206 of 5 starsC$5.27-1.7%C$7.12+35.1%+542.7%C$447.21MC$287.10M-0.672,700EMCEmblemN/A$1.88+1.6%N/A+0.0%$245.45M$5.71M-9.89N/AICCICC LabsN/AC$1.62-5.8%N/A+0.0%C$223.64MC$533,684.0095.29N/AGap UpLEAFLeaf MobileN/AN/AN/AN/AC$198.42MC$83.74M58.86150MGWMaple Leaf Green WorldN/AC$0.79+777.8%N/A+0.0%C$111.69MN/A0.00N/AUpcoming EarningsGap UpBEBeleaveN/AN/AN/AN/A$0.00N/A0.00N/AHigh Trading VolumeBLOCannabix TechnologiesN/AN/AN/AN/AC$0.00N/A0.00N/AGap DownSLSupreme Cannabis Company Inc,N/AN/AN/AN/AC$0.00N/A0.00N/AGap DownHigh Trading VolumeMJNCronos GroupN/AC$12.15-1.9%N/A+0.0%C$1.73BN/A0.007,600 Related Companies and Tools Related Companies CanniMed Therapeutics Competitors Canopy Growth Competitors Emblem Competitors ICC Labs Competitors Leaf Mobile Competitors Maple Leaf Green World Competitors Beleave Competitors Cannabix Technologies Competitors Supreme Cannabis Company Inc, Competitors Cronos Group Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (TSE:OGI) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored24/7 Automated Profits in CryptoThe 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Organigram Holdings Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Organigram With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free OGI Stock Alerts